Astra Antibody Shots Get Emergency FDA Clearance: Virus Update – Bloomberg

The earliest studies on omicron are giving cause for cautious optimism: While vaccines may be less powerful against the new variant, protection can be fortified with boosters. 
Pfizer Inc. and BioNTech SE said initial lab studies show a third dose of their Covid-19 vaccine neutralizes omicron, results that will accelerate global booster drives. AstraZeneca Plc’s antibody cocktail received emergency use authorization from the U.S. Food and Drug Administration. 

source


0Shares

Add a Comment

Your email address will not be published. Required fields are marked *